This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05492682
Recruitment Status : Recruiting
First Posted : August 8, 2022
Last Update Posted : January 12, 2024
Information provided by (Responsible Party):
Valo Therapeutics Oy

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2025
Estimated Study Completion Date : September 2025